Effects of insulin‐like growth factor I treatment on the molecular distribution of insulin‐like growth factors among different binding proteins

The molecular distribution of insulin‐like growth factor I (IGF‐I) and IGF‐II among the IGF binding proteins (IGFBPs) was studied before and during IGF‐I therapy in Ecuadorean adults with growth hormone receptor deficiency (GHRD). Of the total circulating IGF‐I and IGF‐II, 70% was carried by the 150 kDa complex in normal subjects, while in patients with GHRD, 50% of serum IGF‐I, but only 30–35% of serum IGF‐II, was measured within the 150 kDa IGFBP‐3 region. Administration of IGF‐I altered the concentration of IGF‐I and IGF‐II, although the percentage of total IGF measured within each IGFBP region was not affected, as the increase in IGF‐I and the decrease in IGF‐II were proportional. Similarly, serum concentrations of IGFBP‐3 and the acid‐labile subunit, measured by radioimmunoassay, were unaltered. Thus, administration of IGF‐I to patients with GHRD was unable to correct the aberrant distribution of IGFs among the IGFBPs.

[1]  R. Baxter,et al.  The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3. , 1993, The Journal of clinical endocrinology and metabolism.

[2]  J. Guevara-Aguirre,et al.  Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome. , 1993, The Journal of clinical endocrinology and metabolism.

[3]  R. Baxter,et al.  Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. , 1993, The Journal of clinical investigation.

[4]  L. Giudice,et al.  Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting. , 1992, Endocrinology.

[5]  R. Baxter,et al.  Insulin-like growth factor binding protein-3: biochemistry and physiology. , 1992, Growth regulation.

[6]  J. Wallace,et al.  Most of the circulating insulin-like growth factors-I and -II are present in the 150 kDa complex during human pregnancy. , 1991, The Journal of endocrinology.

[7]  S. E. Knowles,et al.  Increased weight gain, nitrogen retention and muscle protein synthesis following treatment of diabetic rats with insulin-like growth factor (IGF)-I and des(1-3)IGF-I. , 1991, The Biochemical journal.

[8]  M. Ranke,et al.  Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. , 1991, The Journal of clinical endocrinology and metabolism.

[9]  J. Wallace,et al.  Insulin-like growth factor-I (IGF-I) and IGF-binding proteins both decline in the rat during late pregnancy. , 1990, The Journal of endocrinology.

[10]  R. Baxter,et al.  Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. , 1990, The Journal of clinical endocrinology and metabolism.

[11]  E. Froesch,et al.  Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Wilson,et al.  Insulin-like growth factors I and II in evaluation of growth retardation. , 1986, The Journal of pediatrics.

[13]  G. Klingensmith,et al.  Effects of human growth hormone administration on serum somatomedins, somatomedin carrier proteins, and growth rates in children with growth hormone deficiency. , 1982, The Journal of clinical endocrinology and metabolism.

[14]  K. Copeland,et al.  Induction of immunoreactive somatomedin C human serum by growth hormone: dose-response relationships and effect on chromatographic profiles. , 1980, The Journal of clinical endocrinology and metabolism.

[15]  M. Rechler.  Insulin-like growth factor binding proteins. , 1993, Vitamins and hormones.

[16]  S. E. Knowles,et al.  Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats. , 1991, The Journal of endocrinology.